Lung cancer: Predicting which patients are at high risk of recurrence to improve outcomes
(Version anglaise seulement)
par Mark Sorin, Étudiant au MD-PhD, chercheur en cancer du poumon, McGill University
Logan Walsh, Assistant Professor, Department of Human Genetics, McGill University
Treatment for lung cancer patients is the same for everyone, regardless of the risk of recurrence. The use of a new technology could refine diagnosis.
Lire l'article complet
© La Conversation
-
lundi 19 février 2024
